Latest Articles

Publication Date
'I'm expecting my first baby after lifechanging endometriosis treatment' - Yorkshire Evening Post

'I'm expecting my first baby after lifechanging endometriosis treatment' Yorkshire Evening Post

Published: March 21, 2026, 6 a.m.
Endometriosis Treatment Bone Health: A New Meta-Analysis - OC Academy

Endometriosis Treatment Bone Health: A New Meta-Analysis OC Academy

Published: March 20, 2026, 5:42 a.m.
Biomaterials for endometriosis treatment: Design, advances, and prospects.

Endometriosis is a chronic gynecological disease characterized by the presence of ectopic endometrium. Achieving effective therapeutic outcomes for endometriosis has always been a significant clinical hurdle because of the high …

Published: March 19, 2026, midnight
The future of endometriosis treatment - The Naked Scientists

The future of endometriosis treatment The Naked Scientists

Published: March 17, 2026, 7:01 p.m.
‘Digital Twinning’ Could Transform Endometriosis Treatment - oha.com

‘Digital Twinning’ Could Transform Endometriosis Treatment oha.com

Published: March 11, 2026, 11:19 p.m.
Endometriosis treatment options aren’t perfect. Can nutrition help? - The Seattle Times

Endometriosis treatment options aren’t perfect. Can nutrition help? The Seattle Times

Published: March 2, 2026, 2 p.m.
Endometriosis Treatment Market to Reach $5.64 Billion by 2033 at 5.4% CAGR – Strategic Revenue Insights (SRI) - industrytoday.co.uk

Endometriosis Treatment Market to Reach $5.64 Billion by 2033 at 5.4% CAGR – Strategic Revenue Insights (SRI) industrytoday.co.uk

Published: Feb. 27, 2026, 9:31 a.m.
Endometriosis Treatment Market Forecast to Hit $5.64 Billion - openPR.com

Endometriosis Treatment Market Forecast to Hit $5.64 Billion openPR.com

Published: Feb. 26, 2026, 2:03 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.
2-Deoxyglucose dendrimer-enabled niclosamide delivery to FRβ-expressing macrophages alleviates endometriosis progression and associated hyperalgesia.

Endometriosis is a chronic, incurable disease. Due to limited efficacy, high recurrence rates, and serious side effects of current treatments, development of new, targeted, non-hormonal therapies is urgently needed. We …

Published: Feb. 12, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!